Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer

NCT02390934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

RADIATION: Radium 223

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris